Cytogenetic and molecular testing in patients with chronic myeloid leukemia (CML) in a prospective observational study (SIMPLICITY).

被引：3

作者：

Goldberg, Stuart L.

Cortes, Jorge E.

Gambacorti-Passerini, Carlo

Hehlmann, Ruediger

Khoury, Hanna Jean

Mauro, Michael J.

Michallet, Mauricette

Paquette, Ronald

Simonsson, Bengt

Foreman, Aimee

Mohamed, Hesham

Subar, Milayna

Zyczynski, Teresa Maria

机构：

[1] John Theurer Canc Ctr, Hackensack, NJ USA

[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[3] Univ Milano Bicocca, Monza, Italy

[4] Heidelberg Univ, Mannheim, Germany

[5] Emory Univ, Winship Canc Inst, Atlanta, GA 30322 USA

[6] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA

[7] Ctr Hosp Lyon Sud, F-69310 Pierre Benite, France

[8] Ronald Reagan UCLA Med Ctr, Los Angeles, CA USA

[9] Univ Uppsala Hosp, Uppsala, Sweden

[10] ICON Clin Res Biostat & Programming, San Francisco, CA USA

[11] Bristol Myers Squibb, Plainsboro, NJ USA

[12] Medco Hlth Solut Inc, Franklin Lakes, NJ USA

[13] Bristol Myers Squibb Co, Princeton, NJ USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2014年 / 32卷 / 15期

关键词：

D O I：

10.1200/jco.2014.32.15_suppl.7050

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

7050

引用

页数：1

共 50 条

[21] 30Dosing Patterns of Dasatinib Use in Simplicity, an Observational Study in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients (pts) in Routine Clinical Practice
Cortes, Jorge E.
Chen, Clara
Mauro, Michael J.
Sen, Ginny P.
Gajavelli, Srikanth
Davis, Catherine
Goldberg, Stuart L.
BLOOD, 2018, 132
[22] Two-year monitoring and treatment patterns in German patients with chronic-phase Chronic Myeloid Leukemia (CP-CML) in a prospective observational study
Tesch, H.
Nusch, A.
Linde, H.
Sen, G. P.
Schollmeyer, A.
Hehlmann, R.
ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 178 - 179
[23] EARLY CYTOGENETIC AND MOLECULAR RESPONSES AND LONG-TERM OUTCOME IN EARLY CHRONIC PHASE CHRONIC MYELOID LEUKEMIA (CML) PATIENTS TREATED WITH NILOTINIB
Gugliotta, G.
Castagnetti, F.
Palandri, F.
Breccia, M.
Levato, L.
Stagno, F.
Luciano, L.
Zaccaria, A.
Rossi, A.
Usala, E.
Gozzini, A.
Carella, A.
Capucci, A.
Musto, P.
Tiribelli, M.
Abruzzese, E.
Avanzini, P.
Soverini, S.
Bochicchio, M.
Testoni, N.
Alimena, G.
Pane, F.
Martinelli, G.
Cavo, M.
Saglio, G.
Baccarani, M.
Rosti, G.
HAEMATOLOGICA, 2013, 98 : 58 - 58
[24] Correlation of three methods of measuring cytogenetic response in chronic myeloid leukemia (CML).
Lesser, ML
DeWald, G
Sison, CP
Silver, RT
BLOOD, 2000, 96 (11) : 111A - 111A
[25] Cytogenetic and molecular genetic evolution of chronic myeloid leukemia
Johansson, B
Fioretos, T
Mitelman, F
ACTA HAEMATOLOGICA, 2002, 107 (02) : 76 - 94
[26] Chronic myeloid leukemia: Relevance of cytogenetic and molecular assays
Bennour, Ayda
Saad, Ali
Sennana, Halima
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 97 : 263 - 274
[27] CYTOGENETIC STUDY OF CHRONIC MYELOID-LEUKEMIA
MICHALOVA, K
MUSILOVA, J
KOUDELOVA, Z
PLACEROVA, J
MATUCHOVA, L
NEOPLASMA, 1988, 35 (05) : 571 - 581
[28] THE ALTERATION OF IMMUNOPROFILE DURING DASATINIB TREATMENT IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: A PROSPECTIVE OBSERVATIONAL STUDY
Kuno, M.
Nakamae, H.
Katayama, T.
Nishimoto, M.
Hayashi, Y.
Hirose, A.
Nakamae, M.
Nakashima, Y.
Koh, H.
Nakane, T.
Hino, M.
HAEMATOLOGICA, 2016, 101 : 457 - 457
[29] Cardiovascular (CV)-Related Hospitalizations and Associated Costs Among US Patients in Simplicity: An Observational Study of Patients with Chronic-Phase Chronic Myeloid Leukemia (CP-CML) in Routine Clinical Practice
Goldberg, Stuart L.
Mauro, Michael J.
Cortes, Jorge E.
Keating, Scott Justin
Bhandari, Hitesh
Chen, Clara
BLOOD, 2019, 134
[30] Cytogenetic and FISH analysis of MDS-related chromosome aberrations in patients with chronic myeloid leukemia (CML)
Mucha, Barbara
Skonieczka, Katarzyna
Calbecka, Malgorzata
Wyrowinska, Elzbieta
Gadomska, Grazyna
Szadziewska, Danuta
Haus, Olga
CHROMOSOME RESEARCH, 2011, 19 : S160 - S160

← 1 2 3 4 5 →